Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Senard

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Fundamental & Clinical Pharmacology|September 21, 2001
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatmentM Pelat, P Verwaerde, M A Tran, et al.
Clinical Neuropharmacology|February 27, 1999
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteersN Andreu, J J Chalé, J M Senard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessmentG Durrieu, M E LLau, O Rascol, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 1, 1994
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogsJ L Montastruc, M Lapeyre-Mestre, M E Llau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's diseaseJ L Montastruc, K Desboeuf, M Lapeyre-Mestre, et al.
Hypertension (Dallas, Tex. : 1979)|November 24, 1999
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertensionM Pelat, P Verwaerde, C Merial, et al.
Journal of Lipid Research|April 6, 2001
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young menJ Galitzky, C Sengenès, C Thalamas, et al.
Clinical Neuropharmacology|October 1, 1996
A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patientsM E Llau, G Durrieu, M A Tran, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1989
Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's diseaseP Celsis, J L Montastruc, O Rascol, et al.
British Journal of Pharmacology|March 1, 1996
A study of tolerance to apomorphineJ L Montastruc, M E Llau, J M Senard, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Fundamental & Clinical Pharmacology|September 21, 2001
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatmentM Pelat, P Verwaerde, M A Tran, et al.
Clinical Neuropharmacology|February 27, 1999
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteersN Andreu, J J Chalé, J M Senard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessmentG Durrieu, M E LLau, O Rascol, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 1, 1994
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogsJ L Montastruc, M Lapeyre-Mestre, M E Llau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's diseaseJ L Montastruc, K Desboeuf, M Lapeyre-Mestre, et al.
Hypertension (Dallas, Tex. : 1979)|November 24, 1999
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertensionM Pelat, P Verwaerde, C Merial, et al.
Journal of Lipid Research|April 6, 2001
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young menJ Galitzky, C Sengenès, C Thalamas, et al.
Clinical Neuropharmacology|October 1, 1996
A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patientsM E Llau, G Durrieu, M A Tran, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1989
Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's diseaseP Celsis, J L Montastruc, O Rascol, et al.
British Journal of Pharmacology|March 1, 1996
A study of tolerance to apomorphineJ L Montastruc, M E Llau, J M Senard, et al.
Pageof 13